跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kemotrexate - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Kemotrexate
Approved
STANDARD
Kemotrexate
Globela Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4bdfe135b7e05d10
Company
Globela Pharma Private Limited
Type
Standard
Approval Details
Approval Id
4bdfe135b7e05d10
Drug Approval Philippines Name
Kemotrexate
Product Name
Kemotrexate
Registration Number
DRP-15073-01
Brand Name
Kemotrexate
Generic Name
Methotrexate
Dosage Form
Tablet
Dosage Strength
2.5 mg
Manufacturer
Globela Pharma Private Limited
Importer
AMB HK Enterprises Inc
Distributor
Keminfinity Inc
Issuance Date
25 July 2024
Expiry Date
12 April 2029
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4bdfe135b7e05d10
Type
Standard
Back to Philippines FDA Approvals